Endpoints News· Max Bayer·· 1 天前AI 评分50
Pfizer 上调 2026 年业绩指引：肿瘤与偏头痛业务增长抵消 Covid 产品下滑
Pfizer lifts 2026 guidance as cancer, migraine sales offset Covid slide
AI 导读
Pfizer 上调 2026 年财务指引，肿瘤与偏头痛业务的强劲增长帮助其抵消 Covid 产品的销售大幅下滑。
正文 · 原文
Pfizer raised its 2026 financial guidance as strong growth in its oncology and migraine businesses helped it weather sharp sales drops in its Covid products.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news